Pierre Van Damme mainly investigates Vaccination, Immunology, Pediatrics, Virology and Immunogenicity. His research in Vaccination intersects with topics in Booster dose, Antibody, Immunization, Family medicine and Public health. His Pediatrics study incorporates themes from Whooping cough, Young adult, Confidence interval, Hepatology and Prospective cohort study.
His Virology research is multidisciplinary, relying on both Serology, Epidemiology and Double blind. The Reactogenicity research Pierre Van Damme does as part of his general Immunogenicity study is frequently linked to other disciplines of science, such as Virus-like particle, therefore creating a link between diverse domains of science. The concepts of his Hepatitis B study are interwoven with issues in Hepatitis B vaccine, Viral disease, Hepatitis, Disease burden and Hepatitis B virus.
The scientist’s investigation covers issues in Vaccination, Immunology, Pediatrics, Virology and Immunogenicity. His Vaccination research integrates issues from Hepatitis A, Hepatitis B, Internal medicine and Immunization. The study incorporates disciplines such as Hepatitis B vaccine, Hepatitis and Hepatitis B virus in addition to Hepatitis B.
In Pediatrics, Pierre Van Damme works on issues like Epidemiology, which are connected to Public health. Pierre Van Damme specializes in Virology, namely Viral disease. His Immunogenicity study combines topics in areas such as Adverse effect, Randomized controlled trial and Influenza vaccine.
Pierre Van Damme mainly investigates Vaccination, Immunogenicity, Internal medicine, Antibody and Immunology. His Vaccination research is multidisciplinary, incorporating perspectives in Hepatitis A, Immunization and Pediatrics. The Pediatrics study which covers Epidemiology that intersects with Clinical trial.
Pierre Van Damme works mostly in the field of Immunogenicity, limiting it down to topics relating to Hepatitis B and, in certain cases, Adjuvant and HBsAg, as a part of the same area of interest. His study in Immunology concentrates on Antigen and Immunity. His work carried out in the field of HPV vaccines brings together such families of science as Transmission and Virology.
Pierre Van Damme mainly focuses on Vaccination, Immunology, Antibody, Internal medicine and Immunization. He is studying Tetanus, which is a component of Vaccination. His study in Immunology focuses on Immune system in particular.
Pierre Van Damme combines subjects such as Serotype and Streptococcus pneumoniae with his study of Internal medicine. His studies in Immunization integrate themes in fields like Disease and Diphtheria. His biological study spans a wide range of topics, including Reactogenicity and Immunogenicity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Timo Vesikari;David O Matson;Penelope Dennehy;Pierre Van Damme.
The New England Journal of Medicine (2006)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)
Comprehensive control of human papillomavirus infections and related diseases.
F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)
The global impact of vaccination against hepatitis B: a historical overview.
Alessandro R. Zanetti;Pierre Van Damme;Daniel Shouval.
Knowledge, Attitudes and Practices in Travel-related Infectious Diseases: The European Airport Survey
Koen Iran Herck;Francesco Castelli;Jane Zuckerman;Hans Nothdurft.
Journal of Travel Medicine (2004)
Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults
Pierre Van Damme;Froukje Oosterhuis-Kafeja;Marie Van der Wielen;Yotam Almagor.
Rotavirus disease and vaccination: impact on genotype diversity
Jelle Matthijnssens;Joke Bilcke;Max Ciarlet;Vito Martella.
Future Microbiology (2009)
Rationale for pertussis booster vaccination throughout life in Europe
Fred Zepp;Ulrich Heininger;Jussi Mertsola;Ewa Bernatowska.
Lancet Infectious Diseases (2011)
Hepatitis A booster vaccination: is there a need?
Pierre Van Damme;J Banatvala;O Fay;S Iwarson.
The Lancet (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: